Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRT064445 (andexanet alfa) SAD study in healthy volunteers
NCT03218241Phase 1Completed
- Sponsor
- Portola Pharmaceuticals
- Start
- Jun 2012
- Primary completion
- Sep 2012
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of andexanet alfa in hemorrhage, sponsored by Portola Pharmaceuticals. Started Jun 2012; status: completed.
02
Drugs
andexanet alfa
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03218241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03218241.